MODERN BIOMARKERS OF CORONARY HEART DISEASE

dc.contributor.authorUmarova T. A.
dc.contributor.authorKudratova Z. E.
dc.contributor.authorAbdullayev Dilshod Xamidullo o’g’li
dc.date.accessioned2025-12-29T17:56:50Z
dc.date.issued2024-12-04
dc.description.abstractAn ideal biomarker of acute myocardial infarction (AMI) should be sensitive and specific early in the course of the disease and have a high prognostic value, which could help clinicians to choose the most optimal treatment tactics. To date, there is no ideal biomarker of AMI, which would have all the characteristics at the same time.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/2370
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/24192
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/2370/2347
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 2 No. 12 (2024): WOM; 27-30
dc.source2938-3765
dc.subjectIntracellular enzyme, acute myocardial infarction, metabolism, glycogenolysis.
dc.titleMODERN BIOMARKERS OF CORONARY HEART DISEASE
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
a_2024_modern_biomarkers_of_coronary_heart_dise.pdf
item.page.filesection.size
269.6 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections